ZIMMER BIOMET HOLDINGS INC (ZBH) Fundamental Analysis & Valuation
NYSE:ZBH • US98956P1021
Current stock price
82.9 USD
+0.47 (+0.57%)
At close:
82.9 USD
0 (0%)
After Hours:
This ZBH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ZBH Profitability Analysis
1.1 Basic Checks
- In the past year ZBH was profitable.
- ZBH had a positive operating cash flow in the past year.
- ZBH had positive earnings in each of the past 5 years.
- Each year in the past 5 years ZBH had a positive operating cash flow.
1.2 Ratios
- With a decent Return On Assets value of 3.05%, ZBH is doing good in the industry, outperforming 75.94% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 5.55%, ZBH is in the better half of the industry, outperforming 77.01% of the companies in the same industry.
- ZBH has a Return On Invested Capital of 5.79%. This is in the better half of the industry: ZBH outperforms 78.07% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for ZBH is below the industry average of 9.14%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 5.55% | ||
| ROIC | 5.79% |
ROA(3y)4.02%
ROA(5y)2.97%
ROE(3y)7%
ROE(5y)5.22%
ROIC(3y)6.56%
ROIC(5y)5.98%
1.3 Margins
- Looking at the Profit Margin, with a value of 8.56%, ZBH belongs to the top of the industry, outperforming 81.28% of the companies in the same industry.
- In the last couple of years the Profit Margin of ZBH has grown nicely.
- ZBH has a better Operating Margin (16.75%) than 87.17% of its industry peers.
- ZBH's Operating Margin has improved in the last couple of years.
- ZBH's Gross Margin of 69.71% is fine compared to the rest of the industry. ZBH outperforms 77.54% of its industry peers.
- ZBH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.75% | ||
| PM (TTM) | 8.56% | ||
| GM | 69.71% |
OM growth 3Y-1.75%
OM growth 5Y9.46%
PM growth 3Y36.96%
PM growth 5YN/A
GM growth 3Y-0.56%
GM growth 5Y0%
2. ZBH Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ZBH is destroying value.
- The number of shares outstanding for ZBH has been reduced compared to 1 year ago.
- The number of shares outstanding for ZBH has been reduced compared to 5 years ago.
- ZBH has a worse debt/assets ratio than last year.
2.2 Solvency
- ZBH has an Altman-Z score of 2.32. This is not the best score and indicates that ZBH is in the grey zone with still only limited risk for bankruptcy at the moment.
- ZBH has a Altman-Z score of 2.32. This is in the better half of the industry: ZBH outperforms 62.57% of its industry peers.
- ZBH has a debt to FCF ratio of 6.72. This is a slightly negative value and a sign of low solvency as ZBH would need 6.72 years to pay back of all of its debts.
- ZBH has a better Debt to FCF ratio (6.72) than 73.26% of its industry peers.
- A Debt/Equity ratio of 0.55 indicates that ZBH is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.55, ZBH is doing worse than 61.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 6.72 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.78
WACC7.45%
2.3 Liquidity
- A Current Ratio of 1.98 indicates that ZBH should not have too much problems paying its short term obligations.
- ZBH's Current ratio of 1.98 is on the low side compared to the rest of the industry. ZBH is outperformed by 64.17% of its industry peers.
- A Quick Ratio of 1.10 indicates that ZBH should not have too much problems paying its short term obligations.
- ZBH's Quick ratio of 1.10 is on the low side compared to the rest of the industry. ZBH is outperformed by 77.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.1 |
3. ZBH Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 7.75% over the past year.
- ZBH shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.66% yearly.
- ZBH shows a small growth in Revenue. In the last year, the Revenue has grown by 7.20%.
- ZBH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.22% yearly.
EPS 1Y (TTM)7.75%
EPS 3Y5.97%
EPS 5Y7.66%
EPS Q2Q%15.47%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y5.85%
Revenue growth 5Y3.22%
Sales Q2Q%9.3%
3.2 Future
- ZBH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.07% yearly.
- Based on estimates for the next years, ZBH will show a small growth in Revenue. The Revenue will grow by 3.89% on average per year.
EPS Next Y3.41%
EPS Next 2Y5.36%
EPS Next 3Y5.71%
EPS Next 5Y6.07%
Revenue Next Year4.21%
Revenue Next 2Y3.99%
Revenue Next 3Y3.89%
Revenue Next 5Y3.89%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ZBH Valuation Analysis
4.1 Price/Earnings Ratio
- ZBH is valuated reasonably with a Price/Earnings ratio of 9.78.
- ZBH's Price/Earnings ratio is rather cheap when compared to the industry. ZBH is cheaper than 92.51% of the companies in the same industry.
- ZBH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.64.
- The Price/Forward Earnings ratio is 9.11, which indicates a very decent valuation of ZBH.
- 95.19% of the companies in the same industry are more expensive than ZBH, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 21.36. ZBH is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.78 | ||
| Fwd PE | 9.11 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ZBH is valued cheaply inside the industry as 92.51% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZBH indicates a rather cheap valuation: ZBH is cheaper than 95.19% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.33 | ||
| EV/EBITDA | 9.29 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZBH does not grow enough to justify the current Price/Earnings ratio.
- ZBH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.87
PEG (5Y)1.28
EPS Next 2Y5.36%
EPS Next 3Y5.71%
5. ZBH Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 1.04%, ZBH has a reasonable but not impressive dividend return.
- ZBH's Dividend Yield is rather good when compared to the industry average which is at 0.26. ZBH pays more dividend than 91.98% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.80, ZBH's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
5.2 History
- The dividend of ZBH has a limited annual growth rate of 0.12%.
- ZBH has paid a dividend for at least 10 years, which is a reliable track record.
- ZBH has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0.12%
Div Incr Years0
Div Non Decr Years13
5.3 Sustainability
- ZBH pays out 27.01% of its income as dividend. This is a sustainable payout ratio.
- ZBH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP27.01%
EPS Next 2Y5.36%
EPS Next 3Y5.71%
ZBH Fundamentals: All Metrics, Ratios and Statistics
82.9
+0.47 (+0.57%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength11.18
Industry Growth59.63
Earnings (Last)04-28 2026-04-28/bmo
Earnings (Next)08-05 2026-08-05/bmo
Inst Owners104.34%
Inst Owner Change-1.43%
Ins Owners0.17%
Ins Owner Change10.9%
Market Cap16.05B
Revenue(TTM)8.23B
Net Income(TTM)704.60M
Analysts66.47
Price Target105.35 (27.08%)
Short Float %5.22%
Short Ratio5.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.04% |
Yearly Dividend0.96
Dividend Growth(5Y)0.12%
DP27.01%
Div Incr Years0
Div Non Decr Years13
Ex-Date03-31 2026-03-31 (0.24)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.37%
Min EPS beat(2)0%
Max EPS beat(2)0.73%
EPS beat(4)4
Avg EPS beat(4)1.33%
Min EPS beat(4)0%
Max EPS beat(4)3.32%
EPS beat(8)6
Avg EPS beat(8)0.88%
EPS beat(12)9
Avg EPS beat(12)2.02%
EPS beat(16)13
Avg EPS beat(16)3.09%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)-0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)0.21%
Revenue beat(8)3
Avg Revenue beat(8)-0.3%
Revenue beat(12)5
Avg Revenue beat(12)0.36%
Revenue beat(16)9
Avg Revenue beat(16)0.9%
PT rev (1m)-0.05%
PT rev (3m)1.06%
EPS NQ rev (1m)0.1%
EPS NQ rev (3m)-2.76%
EPS NY rev (1m)0.01%
EPS NY rev (3m)-1.15%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.78 | ||
| Fwd PE | 9.11 | ||
| P/S | 1.95 | ||
| P/FCF | 14.33 | ||
| P/OCF | 9.46 | ||
| P/B | 1.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.29 |
EPS(TTM)8.48
EY10.23%
EPS(NY)9.1
Fwd EY10.98%
FCF(TTM)5.78
FCFY6.98%
OCF(TTM)8.77
OCFY10.58%
SpS42.53
BVpS65.6
TBVpS-10.16
PEG (NY)2.87
PEG (5Y)1.28
Graham Number111.875 (34.95%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.05% | ||
| ROE | 5.55% | ||
| ROCE | 6.72% | ||
| ROIC | 5.79% | ||
| ROICexc | 5.96% | ||
| ROICexgc | 22.61% | ||
| OM | 16.75% | ||
| PM (TTM) | 8.56% | ||
| GM | 69.71% | ||
| FCFM | 13.6% |
ROA(3y)4.02%
ROA(5y)2.97%
ROE(3y)7%
ROE(5y)5.22%
ROIC(3y)6.56%
ROIC(5y)5.98%
ROICexc(3y)6.74%
ROICexc(5y)6.13%
ROICexgc(3y)26.07%
ROICexgc(5y)24.68%
ROCE(3y)7.62%
ROCE(5y)6.94%
ROICexgc growth 3Y0.14%
ROICexgc growth 5Y10.7%
ROICexc growth 3Y1.16%
ROICexc growth 5Y14.26%
OM growth 3Y-1.75%
OM growth 5Y9.46%
PM growth 3Y36.96%
PM growth 5YN/A
GM growth 3Y-0.56%
GM growth 5Y0%
F-Score5
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.55 | ||
| Debt/FCF | 6.72 | ||
| Debt/EBITDA | 2.8 | ||
| Cap/Depr | 52.79% | ||
| Cap/Sales | 7.01% | ||
| Interest Coverage | 4.62 | ||
| Cash Conversion | 68.63% | ||
| Profit Quality | 158.91% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.1 | ||
| Altman-Z | 2.32 |
F-Score5
WACC7.45%
ROIC/WACC0.78
Cap/Depr(3y)61.71%
Cap/Depr(5y)55.56%
Cap/Sales(3y)8.04%
Cap/Sales(5y)7.33%
Profit Quality(3y)115.26%
Profit Quality(5y)195.51%
High Growth Momentum
Growth
EPS 1Y (TTM)7.75%
EPS 3Y5.97%
EPS 5Y7.66%
EPS Q2Q%15.47%
EPS Next Y3.41%
EPS Next 2Y5.36%
EPS Next 3Y5.71%
EPS Next 5Y6.07%
Revenue 1Y (TTM)7.2%
Revenue growth 3Y5.85%
Revenue growth 5Y3.22%
Sales Q2Q%9.3%
Revenue Next Year4.21%
Revenue Next 2Y3.99%
Revenue Next 3Y3.89%
Revenue Next 5Y3.89%
EBIT growth 1Y-11.53%
EBIT growth 3Y4%
EBIT growth 5Y12.99%
EBIT Next Year27.55%
EBIT Next 3Y10.42%
EBIT Next 5Y8.8%
FCF growth 1Y24.09%
FCF growth 3Y10.12%
FCF growth 5Y7.09%
OCF growth 1Y13.19%
OCF growth 3Y9.72%
OCF growth 5Y7.1%
ZIMMER BIOMET HOLDINGS INC / ZBH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ZIMMER BIOMET HOLDINGS INC?
ChartMill assigns a fundamental rating of 6 / 10 to ZBH.
Can you provide the valuation status for ZIMMER BIOMET HOLDINGS INC?
ChartMill assigns a valuation rating of 7 / 10 to ZIMMER BIOMET HOLDINGS INC (ZBH). This can be considered as Undervalued.
How profitable is ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
ZIMMER BIOMET HOLDINGS INC (ZBH) has a profitability rating of 7 / 10.
What is the financial health of ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
The financial health rating of ZIMMER BIOMET HOLDINGS INC (ZBH) is 4 / 10.
What is the expected EPS growth for ZIMMER BIOMET HOLDINGS INC (ZBH) stock?
The Earnings per Share (EPS) of ZIMMER BIOMET HOLDINGS INC (ZBH) is expected to grow by 3.41% in the next year.